PerkinElmer Inc., a Wellesly, Mass.-based global provider of technology for markets including photonics, life and analytical sciences, optoelectronics and fluid sciences, announced today that Richard Eglen has joined the company as vice president and general manager, discovery and research reagents, for PerkinElmer's Life & Analytical Sciences unit. Eglen joins PerkinElmer from DiscoveRx, where he was chief scientific officer and executive vice president for research and development. Before that, he worked for more than 20 years in executive positions in the pharmaceutical, diagnostic and biotech industries. Eglen has a PhD in molecular pharmacology from Trent University in Nottingham, England. He has been published in more than 250 scientific papers and books and holds several patents, many of which focus on key drug discovery targets such as GPCRs, kinases and ion channels. He also holds several patents relating to novel technologies for enabling drug discovery and other types of research. He serves on numerous journal editorial boards and is on the board of the Society for BioMolecular Sciences.